Skip to main content
. Author manuscript; available in PMC: 2011 Jul 21.
Published in final edited form as: Psychopharmacology (Berl). 2011 Jan 19;215(4):665–675. doi: 10.1007/s00213-010-2162-7

Table 2.

ED50 values and 95% confidence limits for drugs to decrease rate of operant responding (Response Rate) and rectal temperature (Temperature) before, during, and after discontinuation of daily Δ9-THC (32 mg/kg) treatment

ED50 in mg/kg (95% confidence limits) Potency ratioa (95% confidence limits)
Δ9-THC response rate
    Before 5.64 (3.52–9.03)
    During 46b (3.7–570) 8.2 (1.4–48)
    After 17.9b (7.23–44.5) 3.2 (1.4–7.5)
Δ9-THC temperature
    Before 10.2 (7.06–14.8)
    During c
    After 23.0b (15.8–33.5) 2.3 (1.4–3.7)
CP 55940 response rate
    Before 0.12 (0.069–0.21)
    During 0.20 (0.11–0.35) 1.7 (0.8–3.5)
    After 0.17 (0.049–0.60) 1.4 (0.5–4.1)
CP 55940 temperature
    Before 0.48 (0.37–0.67)
    During c
    After 2.01b (1.26–3.18) 4.2 (2.5–7.2)
Anandamide response rate
    Before 5.45 (3.42–8.69)
    During 7.46 (3.23–17.2) 1.4 (0.6–2.9)
    After 5.25 (3.32–8.31) 1.0 (0.5–1.8)
Anandamide temperature
    Before 19.2 (15.3–24.2)
    During 20.4 (14.7–28.4) 1.1 (0.7–1.6)
    After 16.1 (12.4–20.7) 0.8 (0.6–1.2)
Midazolam response rate
    Before 4.03 (2.54–6.41)
    During 23.3 (13.1–41.3) d
    After 4.37 (2.32–8.23) 1.1 (0.5–2.2)
Midazolam temperature
    Before 11.0 (6.65–18.3)
    During 22.4 (8.25–60.7) 2.0 (0.8–5.4)
    After 9.77 (5.65–16.9) 0.9 (0.4–1.8)
a

Potency ratios and 95% confidence limits are ED50 values determined during or after discontinuation of Δ9-THC treatment divided by the ED50 value determined before Δ9-THC treatment

b

Significantly different from Before

c

ED50 value not determined; the largest dose did not produce greater than 50% effect

d

Potency ratio not calculated because slopes were significantly different